# Cellares raises $255M for cell therapy Smart Factory in Bridgewater

Cellares secured $255 million in Series C funding to launch a commercial-scale Integrated Development and Manufacturing Organization Smart Factory in Bridgewater, New Jersey. The 118,000-square-foot facility will integrate advanced robotics for cell therapy manufacturing.

- Type: Investment
- Announced: 2023-08-23
- Where: Bridgewater, New Jersey, United States
- Value: $255.0M
- Status: announced
- Products: cell therapies
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Cellares](https://endata.com/companies/72237.md)
- [Bristol Myers Squibb](https://endata.com/companies/67799.md) (investor)
- [Koch Disruptive Technologies](https://endata.com/companies/72238.md) (investor)

## Sources

- [njbiz.com](https://njbiz.com/cellares-raises-255m-for-bridgewater-cell-therapy-development-facility/), 2023-08-24: "Cell therapy manufacturer Cellares has secured $255 million in Series C funding that will be used to launch the world’s first commercial-scale Integrated Development and Manufacturing Organization Smart Factory in Bridgewater."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.